KATELYN TOURVILLE: Open Payments
NPI 1730734831 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 8 payments from 7 companies in 2025. Trend: 2023 $56 · 2024 $0 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: JARDIANCE, CAPLYTA, REPATHA, FANAPT, LYBALVI, Auvelity.
Industry payments across MI — which companies pay providers there.
